DRKS00015439
Completed
N/A
Assessment of safety and glycaemia during application of the hybrid closed-loop system on the basis of the AndroidAPS application. - ASCENT
Diabetes Poland0 sites12 target enrollmentSeptember 4, 2018
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- E10
- Sponsor
- Diabetes Poland
- Enrollment
- 12
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. age 18\-40
- •2\. type 1 diabetes
- •3\. duration of diabetes \> 5 years
- •4\. treatment with a personal insulin pump from \> 1 year
- •5\. using the bolus calculator
- •6\. experience in CGM system: using o f\= 70% of the time in the last 3 months
- •7\. HbA1c \<9%
- •8\. BMI 18\-30 kg / m2
- •9\. consent to participate in the study
Exclusion Criteria
- •1\. persistence of partial remission of type 1 diabetes
- •2\. identified advanced chronic micro\- and macroangiopathic complications of diabetes (proliferative retinopathy, diabetic kidney disease with eGFR \<60 mL/min/1\.73 m2, cardiac autonomic neuropathy, coronary heart disease, stroke)
- •3\. severe hypoglycemia in the last year
- •4\. hypoglycemia unawareness
- •5\. ketoacidosis in the last 3 months
- •6\. accompanying diseases except hypothyroidism in the state of euthyreosis
- •7\. eating disorders, depression
- •8\. smoking
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysisACTRN12612000352808Dr Tilenka Thynne6
Not Yet Recruiting
Phase 2
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on peritoneal dialysisType 2 DiabetesChronic kidney Disease- on peritoneal dialysisMetabolic and Endocrine - DiabetesRenal and Urogenital - Kidney diseaseACTRN12612000864820Tilenka Thynne6
Unknown
N/A
Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICUBlood Glucose Monitoring in Medical ICUNCT02142088GlySure60
Unknown
N/A
Effects on Glycemic Control of WBF-0031 in Subjects With Abnormal Glucose ToleranceAbnormal Glucose ToleranceNCT04490460Eden Miller30
Withdrawn
N/A
GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life PracticeDiabetes Mellitus, Type 2NCT01915264Bayer